T1	Participants 109 139	rheumatoid arthritis patients.
T2	Participants 378 422	patients with rheumatoid arthritis (RA), and
T3	Participants 985 1116	Sixty-eight RA patients (age=55±13 years, body mass index: 27.8±5.4 kg/m2, median of disease duration=5 (2-8) yrs) were recruited
